134 related articles for article (PubMed ID: 37003144)
21. Low dose aspirin increases 15-epi-lipoxin A4 levels in diabetic chronic kidney disease patients.
Goicoechea M; Sanchez-Niño MD; Ortiz A; García de Vinuesa S; Quiroga B; Bernis C; Morales E; Fernández-Juarez G; de Sequera P; Verdalles U; Verde E; Luño J
Prostaglandins Leukot Essent Fatty Acids; 2017 Oct; 125():8-13. PubMed ID: 28987723
[TBL] [Abstract][Full Text] [Related]
22. Effect of DHA supplementation on oxylipin levels in plasma and immune cell stimulated blood.
Schuchardt JP; Ostermann AI; Stork L; Fritzsch S; Kohrs H; Greupner T; Hahn A; Schebb NH
Prostaglandins Leukot Essent Fatty Acids; 2017 Jun; 121():76-87. PubMed ID: 28651702
[TBL] [Abstract][Full Text] [Related]
23. Combined administration of resolvin E1 and lipoxin A4 resolves inflammation in a murine model of Alzheimer's disease.
Kantarci A; Aytan N; Palaska I; Stephens D; Crabtree L; Benincasa C; Jenkins BG; Carreras I; Dedeoglu A
Exp Neurol; 2018 Feb; 300():111-120. PubMed ID: 29126887
[TBL] [Abstract][Full Text] [Related]
24. Formation of lipoxins and resolvins in human leukocytes.
Kahnt AS; Schebb NH; Steinhilber D
Prostaglandins Other Lipid Mediat; 2023 Jun; 166():106726. PubMed ID: 36878381
[TBL] [Abstract][Full Text] [Related]
25. Combination of aspirin with essential fatty acids is superior to aspirin alone to prevent or ameliorate sepsis or ARDS.
Das UN
Lipids Health Dis; 2016 Nov; 15(1):206. PubMed ID: 27887602
[TBL] [Abstract][Full Text] [Related]
26. Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation.
Oh SF; Pillai PS; Recchiuti A; Yang R; Serhan CN
J Clin Invest; 2011 Feb; 121(2):569-81. PubMed ID: 21206090
[TBL] [Abstract][Full Text] [Related]
27. Low-dose aspirin increases 15-epi-lipoxins A
Gonzalez-Brown VM; Ma'ayeh M; Kniss DA; Cackovic M; Landon MB; Rood KM
Pregnancy Hypertens; 2021 Dec; 26():75-78. PubMed ID: 34563982
[TBL] [Abstract][Full Text] [Related]
28. Angioplasty triggers intracoronary leukotrienes and lipoxin A4. Impact of aspirin therapy.
Brezinski DA; Nesto RW; Serhan CN
Circulation; 1992 Jul; 86(1):56-63. PubMed ID: 1617790
[TBL] [Abstract][Full Text] [Related]
29. Celecoxib use and circulating oxylipins in a colon polyp prevention trial.
Martinez JA; Yang J; Wertheim BC; Roe DJ; Schriewer A; Lance P; Alberts DS; Hammock BD; Thompson PA
PLoS One; 2018; 13(4):e0196398. PubMed ID: 29698447
[TBL] [Abstract][Full Text] [Related]
30. Comparison of free serum oxylipin concentrations in hyper- vs. normolipidemic men.
Schuchardt JP; Schmidt S; Kressel G; Dong H; Willenberg I; Hammock BD; Hahn A; Schebb NH
Prostaglandins Leukot Essent Fatty Acids; 2013 Jul; 89(1):19-29. PubMed ID: 23694766
[TBL] [Abstract][Full Text] [Related]
31. Oxylipin status, before and after LC n-3 PUFA supplementation, has little relationship with skeletal muscle biology in older adults at risk of sarcopenia.
de Marco Castro E; Kampschulte N; Murphy CH; Schebb NH; Roche HM
Prostaglandins Leukot Essent Fatty Acids; 2023 Feb; 189():102531. PubMed ID: 36645979
[TBL] [Abstract][Full Text] [Related]
32. The oxylipin profile is associated with development of type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY).
Buckner T; Vanderlinden LA; DeFelice BC; Carry PM; Kechris K; Dong F; Fiehn O; Frohnert BI; Clare-Salzler M; Rewers M; Norris JM
Diabetologia; 2021 Aug; 64(8):1785-1794. PubMed ID: 33893822
[TBL] [Abstract][Full Text] [Related]
33. Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation.
Clària J; Lee MH; Serhan CN
Mol Med; 1996 Sep; 2(5):583-96. PubMed ID: 8898374
[TBL] [Abstract][Full Text] [Related]
34. Effects of prenatal n-3 fatty acid supplementation on offspring resolvins at birth and 12 years of age: a double-blind, randomised controlled clinical trial.
See VHL; Mas E; Prescott SL; Beilin LJ; Burrows S; Barden AE; Huang RC; Mori TA
Br J Nutr; 2017 Dec; 118(11):971-980. PubMed ID: 29173199
[TBL] [Abstract][Full Text] [Related]
35. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cells.
Fierro IM; Colgan SP; Bernasconi G; Petasis NA; Clish CB; Arita M; Serhan CN
J Immunol; 2003 Mar; 170(5):2688-94. PubMed ID: 12594298
[TBL] [Abstract][Full Text] [Related]
36. Free fatty acid receptor 4 responds to endogenous fatty acids to protect the heart from pressure overload.
Murphy KA; Harsch BA; Healy CL; Joshi SS; Huang S; Walker RE; Wagner BM; Ernste KM; Huang W; Block RC; Wright CD; Tintle N; Jensen BC; Wells QS; Shearer GC; O'Connell TD
Cardiovasc Res; 2022 Mar; 118(4):1061-1073. PubMed ID: 33752243
[TBL] [Abstract][Full Text] [Related]
37. Effects of a 12-week high-α-linolenic acid intervention on EPA and DHA concentrations in red blood cells and plasma oxylipin pattern in subjects with a low EPA and DHA status.
Greupner T; Kutzner L; Nolte F; Strangmann A; Kohrs H; Hahn A; Schebb NH; Schuchardt JP
Food Funct; 2018 Mar; 9(3):1587-1600. PubMed ID: 29459911
[TBL] [Abstract][Full Text] [Related]
38. Clinical response to EPA supplementation in patients with major depressive disorder is associated with higher plasma concentrations of pro-resolving lipid mediators.
Lamon-Fava S; Liu M; Dunlop BW; Kinkead B; Schettler PJ; Felger JC; Ziegler TR; Fava M; Mischoulon D; Rapaport MH
Neuropsychopharmacology; 2023 May; 48(6):929-935. PubMed ID: 36635595
[TBL] [Abstract][Full Text] [Related]
39. Icosapent ethyl in cardiovascular prevention: Resolution of inflammation through the eicosapentaenoic acid - resolvin E1 - ChemR23 axis.
Bäck M
Pharmacol Ther; 2023 Jul; 247():108439. PubMed ID: 37201735
[TBL] [Abstract][Full Text] [Related]
40. Predictors of oxylipins in a healthy pediatric population.
Buckner T; Vanderlinden LA; Johnson RK; DeFelice BC; Carry PM; Seifert J; Waugh K; Dong F; Fiehn O; Clare-Salzler M; Rewers M; Norris JM
Pediatr Res; 2021 May; 89(6):1530-1540. PubMed ID: 32726799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
